Depression treatment
Deprexis online therapy reduced depression scores
Open access · cc by · source: Europe PMC
An integrative online program (Deprexis) improved BDI depression symptoms versus delayed treatment in a large German internet RCT.
Study at a glance
- Design
- RCT — Immediate Deprexis vs delayed treatment; online recruitment
- N
- N=396 · 81% assigned to immediate treatment
- Population
- Adults with depression symptoms recruited online for Deprexis
- Outcome
- BDI change over time (condition × time)
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Immediate treatment improved ~5.4 BDI points (d=0.58) with a significant condition×time interaction; delayed group showed essentially no BDI change over the same interval.
Methodology
Researchers randomized 396 adults recruited online to immediate Deprexis treatment or delayed treatment and compared BDI and functioning over time.
Limitations
How Deprexis compares head-to-head with face-to-face CBT, or effects in people without internet access/forum recruitment.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Multiple studies in this library examine depression treatment with empirical patient or population outcomes rather than opinion alone.
Evidence for the claim as stated.
Immediate treatment improved ~5.4 BDI points (d=0.58) with a significant condition×time interaction; delayed group showed essentially no BDI change over the same interval.
Evidence for the claim as stated.
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Evidence for the claim as stated.
Adjunctive smartphone CBT in antidepressant-refractory major depression used ITT on 164 randomised participants: at week 9 the Kokoro-app arm scored about 2.5 PHQ-9 points lower (SMD 0.40) and was more likely to meet response criteria, while remission and side-effect differences were not significant. Deprexis, in 396 adults recruited online, improved BDI by about 5.4 points (d=0.58) versus delayed treatment. Neither ITT result is a head-to-head against face-to-face CBT or a long-term relapse trial.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Supports · Wine, alcohol, and depression
- Supports · Depression linked to C. difficile infection risk
Related papers in this topic
Same topic cluster — not a recommendation engine.